1.43BUSD
Type
Common Stock
Exchange
PINK
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
-
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
17.02
PEG Ratio
-
Book Value
14.18
Dividend Share
0.04
Dividend Yield
0.13%
Earnings Share
1.88
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
707,000,000
Gross Profit TTM
247,700,000
EBITDA
100,250,000
Profit Margin
9.69%
Return On Assets TTM
3.24%
Return On Equity TTM
13.88%
Revenue Per Share TTM
17.851
Qtly Revenue Growth YOY
-33.00%
Diluted Eps TTM
1.88
Qtly Earnings Growth YOY
-56.40%
Trailing PE
17.02
Forward PE
476
Price Sales TTM
2.0979
Price Book MRQ
2.2164
Enterprise Value Revenue
2
Enterprise Value EBITDA
21
98.50
6.14%244.99
2.61%591.45
1.76%100.00
1.71%249.00
1.34%494.74
1.33%78.89
0.66%184.83
0.00%689.50
-3.89%155.48
-0.30%